Pfizer is strengthening the warning on its anti-smoking treatment Chantix due to reports of suicidal tendencies, agitation and depression in adults taking the drug. The company, which made the change after consultations with the FDA, is placing the warning on a more prominent part of the drug's label.

Related Summaries